Jay Evans, PhD 

chief scientific officer, inimmune corp.

Jay Evans is the Chief Scientific Officer of Inimmune Corporation (Missoula, MT) and Director of the Center for Translational Medicine at the University of Montana. He has over 20 years’ experience in the biotechnology and pharmaceutical industry including 15 years at GlaxoSmithKline Vaccines (formerly Corixa Corporation) where he held various roles including North American Pre-Clinical Innovation Team Leader, Project Leader, and Investigator. Dr. Evans completed his Postdoctoral Fellowship at the University of Texas Southwestern Medical Center and St. Jude Children’s Research Hospital working in HIV immunology, stem cell transplantation, and vector-based gene therapy systems. Dr. Evans holds a Ph.D. in Molecular and Cellular Biology from Oregon State University and a B.S. in Biology from Pacific Lutheran University. His research is focused on the discovery and development of novel vaccines, adjuvants and immunotherapeutics across a broad range of disease targets including SARS-CoV-2, Monkeypox, influenza virus, pertussis, tuberculosis, pseudomonas, cancer immunotherapy, opioid addiction, and allergy. He has published over 50 peer reviewed research articles and 15 patents on vaccines, adjuvants, and immunotherapy.